Cost of Hypertension Therapy in Tertiary Health Facilities in Bayelsa State, Nigeria – Patients’ Perspective
Journal of Basic and Social Pharmacy Research · 2021
DOI: 10.52968/27451629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Social Pharmacy Research, 2021. Verfasst von B.A. Joseph und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background - Funding needs to be sustainable for hypertension treatment so there is need to evaluate the cost of therapy regularly to guide decision making. Objective - The aim is to evaluate the cost of achieving goal blood pressure (BP) of 139mmHg systolic and or 89mmHg diastolic from the patients’ perspective in 2 tertiary health facilities. Methods – Folders of clinically diagnosed hypertensive adult patients aged 21-80years in 2 tertiary health facilities were surveyed retrospectively. Sampling was by systematic random sampling technique choosing every third folder from a list. Sample size was calculated with Cochrane formula for population less than 10,000. Out of 723 folders reviewed 227(31.4%) achieved goal BP. Cost of therapy was computed for the 227 folders using the facility price list and local costs for transportation and BP monitoring. Bottom-up, Sum_ Diagnosis specific technique was used to compute component costs excluding intangible costs. Discounting and sensitivity tests were not applicable. Results - The cost range was NGN3,105-NGN35,350($8.87-$101) per patient for 30days Mean monthly patient cost was NGN10,460.38 ($30). Proportion of component costs in total costs was as follows, Laboratory tests 35.17%, Medicines 31.89%, Hospital charges 22.86%, Transportation 5.58%, Income loss 2.53% and BP monitoring 1.97%. The pattern revealed one facility had slightly higher costs and lower proportion of patients reaching goal BP. Conclusion – Cost of therapy was too high. Monthly cost range was 17.5-19.6% of minimum wage. Policy makers need to adopt strategies to reduce cost and protect hypertensive patients.
Zitieren
APA
Joseph, B., Eniojukan, J., Suleiman, I., & Momo, A. (2021). Cost of Hypertension Therapy in Tertiary Health Facilities in Bayelsa State, Nigeria – Patients’ Perspective. Journal of Basic and Social Pharmacy Research. https://doi.org/10.52968/27451629
Vancouver
Joseph B, Eniojukan J, Suleiman I, Momo A. Cost of Hypertension Therapy in Tertiary Health Facilities in Bayelsa State, Nigeria – Patients’ Perspective. Journal of Basic and Social Pharmacy Research. 2021. doi:10.52968/27451629
BibTeX
@article{Joseph2021,
author = {Joseph, B.A. and Eniojukan, J.F. and Suleiman, I.A. and Momo, A.},
title = {Cost of Hypertension Therapy in Tertiary Health Facilities in Bayelsa State, Nigeria – Patients’ Perspective},
journal = {Journal of Basic and Social Pharmacy Research},
year = {2021},
doi = {10.52968/27451629}
}
EUVIMED